CY1109018T1 - Φαρμακευτικη συνθεση που περιεχει ενα αλας μιρταζαπινης - Google Patents

Φαρμακευτικη συνθεση που περιεχει ενα αλας μιρταζαπινης

Info

Publication number
CY1109018T1
CY1109018T1 CY20091100481T CY091100481T CY1109018T1 CY 1109018 T1 CY1109018 T1 CY 1109018T1 CY 20091100481 T CY20091100481 T CY 20091100481T CY 091100481 T CY091100481 T CY 091100481T CY 1109018 T1 CY1109018 T1 CY 1109018T1
Authority
CY
Cyprus
Prior art keywords
salt
mirtazapin
pharmaceutical composition
composition containing
mirtazapine
Prior art date
Application number
CY20091100481T
Other languages
English (en)
Inventor
Sytske Hyke Moolenaar
Gerardus Johannes Kemperman
Der Voort Maarschalk Kees Van
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of CY1109018T1 publication Critical patent/CY1109018T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Η εφεύρεση παρέχει ένα φαρμακευτικά κατάλληλο στερεό άλας που δεν εξαχνώνεται ενός εναντιομερούς της μιρταζαπίνης, ειδικότερα, ένα άλας μιρταζαπίνης που επιλέγεται από τον κατάλογο του άλατος μηλεϊνικού οξέος, υδροβρωμικού οξέος και φουμαρικού οξέος, για χρήση στην παραγωγή μια φαρμακευτικής σύνθεσης που περιλαμβάνει ένα άλας της S- ή της R-μιρταζαπίνης.
CY20091100481T 2004-04-21 2009-05-05 Φαρμακευτικη συνθεση που περιεχει ενα αλας μιρταζαπινης CY1109018T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04101664 2004-04-21
EP05740221A EP1729777B1 (en) 2004-04-21 2005-04-19 Pharmaceutical composition comprising a salt of mirtazapine

Publications (1)

Publication Number Publication Date
CY1109018T1 true CY1109018T1 (el) 2014-07-02

Family

ID=34928990

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100481T CY1109018T1 (el) 2004-04-21 2009-05-05 Φαρμακευτικη συνθεση που περιεχει ενα αλας μιρταζαπινης

Country Status (31)

Country Link
US (1) US20070111993A1 (el)
EP (1) EP1729777B1 (el)
JP (2) JP5260959B2 (el)
CN (2) CN1942191B (el)
AR (1) AR049028A1 (el)
AT (1) ATE424210T1 (el)
AU (1) AU2005235383B2 (el)
BR (1) BRPI0509953A (el)
CA (1) CA2561281C (el)
CY (1) CY1109018T1 (el)
DE (1) DE602005013066D1 (el)
DK (1) DK1729777T3 (el)
EC (1) ECSP066938A (el)
ES (1) ES2321961T3 (el)
HR (1) HRP20090190T1 (el)
IL (1) IL178201A (el)
LV (1) LV13556B (el)
MX (1) MXPA06011830A (el)
MY (1) MY144899A (el)
NO (1) NO20065077L (el)
NZ (1) NZ550052A (el)
PE (1) PE20060400A1 (el)
PL (1) PL1729777T3 (el)
PT (1) PT1729777E (el)
RS (1) RS50764B (el)
RU (1) RU2375362C2 (el)
SI (1) SI1729777T1 (el)
TW (1) TW200538100A (el)
UA (1) UA89773C2 (el)
WO (1) WO2005102352A1 (el)
ZA (1) ZA200608305B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
EP1792618A1 (en) * 2005-11-30 2007-06-06 Rainer Freynhagen R-mirtazapine for the treatment of pain
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
CN104095824B (zh) * 2013-04-09 2016-08-31 上海信谊万象药业股份有限公司 一种米氮平缓释片及其制备方法
US10603272B2 (en) 2015-02-27 2020-03-31 Kindred Biosciences, Inc. Stimulation of appetite and treatment of anorexia in dogs and cats
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4193828A (en) * 1976-07-27 1980-03-18 Fiber Materials, Inc. Method of forming carbon composites
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
PT1067934E (pt) * 1998-04-02 2004-03-31 Akzo Nobel Nv Solucao anti-depressiva liquida oral
WO2001000196A2 (en) * 1999-06-25 2001-01-04 University Of South Florida Mirtazapine for weight gain in wasting diseases
US6281207B1 (en) * 1999-09-15 2001-08-28 Reed Richter Treatment of movement disorders by administration of mirtazapine
AU6474200A (en) * 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
KR20020086945A (ko) * 2000-04-05 2002-11-20 악조 노벨 엔.브이. 비스테로이드성 항염증제를 포함하는 두통 치료용 약제조합물

Also Published As

Publication number Publication date
EP1729777A1 (en) 2006-12-13
CA2561281A1 (en) 2005-11-03
MXPA06011830A (es) 2007-03-23
JP2013136626A (ja) 2013-07-11
CN1942191B (zh) 2011-02-02
ZA200608305B (en) 2008-08-27
MY144899A (en) 2011-11-30
UA89773C2 (ru) 2010-03-10
CA2561281C (en) 2013-04-02
HRP20090190T1 (en) 2009-05-31
IL178201A (en) 2010-06-30
CN101824035A (zh) 2010-09-08
SI1729777T1 (sl) 2009-08-31
PL1729777T3 (pl) 2009-07-31
JP2007533705A (ja) 2007-11-22
AU2005235383B2 (en) 2010-05-27
AR049028A1 (es) 2006-06-21
ECSP066938A (es) 2006-12-20
US20070111993A1 (en) 2007-05-17
CN1942191A (zh) 2007-04-04
DE602005013066D1 (de) 2009-04-16
PT1729777E (pt) 2009-04-27
LV13556B (en) 2007-07-20
BRPI0509953A (pt) 2007-09-25
RU2006140988A (ru) 2008-05-27
AU2005235383A1 (en) 2005-11-03
JP5260959B2 (ja) 2013-08-14
RS50764B (sr) 2010-08-31
DK1729777T3 (da) 2009-06-08
RU2375362C2 (ru) 2009-12-10
NZ550052A (en) 2010-02-26
ATE424210T1 (de) 2009-03-15
NO20065077L (no) 2006-11-14
ES2321961T3 (es) 2009-06-15
PE20060400A1 (es) 2006-05-27
TW200538100A (en) 2005-12-01
WO2005102352A1 (en) 2005-11-03
EP1729777B1 (en) 2009-03-04
IL178201A0 (en) 2006-12-31

Similar Documents

Publication Publication Date Title
NL301113I1 (nl) Tucatinib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout of solvaat
AP2139A (en) 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors.
DE602005014382D1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb-kinaseinhibitoren
MX2007002189A (es) Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
ATE526318T1 (de) Farnesoid-x-rezeptor-agonisten
CY1109018T1 (el) Φαρμακευτικη συνθεση που περιεχει ενα αλας μιρταζαπινης
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
GB2453058A (en) Kinase antagonists
NO20052496D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
ATE413162T1 (de) Pharmazeutische zusammensetzungen zur sicheren verabreichung von bei der behandlung von drogenabhängigkeit verwendeten arzneimitteln
EP2617431A3 (en) Polypeptide inhibitors of HSP27 kinase and uses therefor
HK1103073A1 (en) Substituted diaza-spiro-[5.5-undecane derivatives and their use as neurokinin antagonists
WO2007056625A3 (en) Thienopyridine b-raf kinase inhibitors
CY1105980T1 (el) Βελτιωμενη διαδικασια παρασκευης υδροβρωμικου αλατος του αλφα-πολυμορφικου ελετριπτανιου
EA200602017A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
EA200501697A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
UA91988C2 (ru) Фармацевтическая композиция на основе антагонистов nk2 для применения в педиатрии
UA92180C2 (en) Benzimidazole thiophene compounds as plk inhibitors
CL2007001738A1 (es) Compuestos derivados de cianopiridinas; composicion farmaceutica; y uso para el tratamiento o inhibicion de un trastorno mediado por una proteina quinasa, tal como enfermedad autoinmune e inflamatoria.
CL2007001737A1 (es) Compuestos derivados de cianopiridinas; inhibidores de proteina quinasa;composicion farmaceutica;y uso para el tratamiento o inhibicion de un trastorno mediado por una proteina quinasa,tal como enfermedad autoinmune e inflamatoria.
CY1108865T1 (el) Υποκατεστημενες 2,5-διαμινομευθυλο-1η-πυρρολες
CY1105785T1 (el) Μεθοδοι παρασκευης της 2-(7-χλωρο-1,8-ναφθυριδιν-2-υλ)-3-(5-μεθυλ-2-οξο-εξυλ)-1-ισοϊνδολινονης
TH92464B (th) สารประกอบ
CY1115436T1 (el) Αναστολεις της κινασης p70 s6